User talk:Hekerui

Page contents not supported in other languages.
Source: Wikipedia, the free encyclopedia.

WikiProject Good Articles Recruitment Centre

Hello! Now, some of you might have already received a similar message a little while ago regarding the Recruitment Centre, so if you have, there is no need to read the rest of this. This message is directed to users who have reviewed over 15 Good article nominations and are not part of WikiProject Good articles (the first message I sent out went to only WikiProject members).

So for those who haven't heard about the Recruitment Centre yet, you may be wondering why there is a Good article icon with a bunch of stars around it (to the right). The answer? WikiProject Good articles will be launching a Recruitment Centre very soon! The centre will allow all users to be taught how to review Good article nominations by experts just like you! However, in order for the Recruitment Centre to open in the first place, we need some volunteers:

  • Recruiters: The main task of a recruiter is to teach users that have never reviewed a Good article nomination how to review one. To become a recruiter, all you have to do is meet this criteria. If we don't get at least 5-10 recruiters to start off with (at the time this message was sent out, 2 recruiters have volunteered), the Recruitment Centre will not open. If interested, make sure you meet the criteria, read the process and add your name to the list of recruiters. (One of the great things about being a recruiter is that there is no set requirement of what must be taught and when. Instead, all the content found in the process section is a guideline of the main points that should be addressed during a recruitment session...you can also take an entire different approach if you wish!) If you think you will not have the time to recruit any users at this time but are still interested in becoming a recruiter, you can still add your name to the list of recruiters but just fill in the "Status" parameter with "Not Available".
  • Co-Director: The current Director for the centre is me (Dom497). Another user that would be willing to help with some of the tasks would be helpful. Tasks include making sure recruiters are doing what they should be (teaching!), making sure all recruitments are archived correctly, updating pages as needed, answering any questions, and distributing the feedback form. If interested, please contact me (Dom497).
  • Nominators, please read this: If you are not interested in becoming a recruiter, you can still help. In some cases a nominator may have an issue with an "inexperienced" editor (the recruitee) reviewing one of their nominations. To minimize the chances of this happening, if you are fine with a recruitee reviewing one of your nominations under the supervision of the recruiter, please add your name to the list at the bottom of this page. By adding your name to this list, chances are that your nomination will be reviewed more quickly as the recruitee will be asked to choose a nomination from the list of nominators that are OK with them reviewing the article.

If you have any questions please do not hesitate to contact me. I look forward to seeing this program bring new reviewers to the Good article community and all the positive things it will bring along.

A message will be sent out to all recruiters regarding the date when the Recruitment Centre will open when it is determined. The message will also contain some further details to clarify things that may be a bit confusing.--Dom497 (talk)

This message was sent out by --EdwardsBot (talk) 14:54, 9 June 2013 (UTC)[reply]

German translation

Hello. I was on Wikipedia:Translators available and notice that you were on the list for German to English translators and wondered if you could translate content from de:Ludwig Gaston von Sachsen-Coburg und Gotha to Prince Ludwig Gaston of Saxe-Coburg and Gotha?--The Emperor's New Spy (talk) 20:48, 28 June 2013 (UTC)[reply]

File source problem with File:Gopalswamy D. Naidu.jpg

Thank you for uploading File:Gopalswamy D. Naidu.jpg. I noticed that the file's description page currently doesn't specify who created the content, so the copyright status is unclear. If you did not create this file yourself, you will need to specify the owner of the copyright. If you obtained it from a website, please add a link to the page from which it was taken, together with a brief restatement of the website's terms of use of its content. If the original copyright holder is a party unaffiliated with the website, that author should also be credited. Please add this information by editing the image description page.

If the necessary information is not added within the next days, the image will be deleted. If the file is already gone, you can still make a request for undeletion and ask for a chance to fix the problem.

Please refer to the

image use policy to learn what images you can or cannot upload on Wikipedia. Please also check any other files you have uploaded to make sure they are correctly tagged. Here is a list of your uploads. If you have any questions or are in need of assistance please ask them at the Media copyright questions page. Thank you. Sitush (talk) 13:48, 15 September 2013 (UTC)[reply
]

Talkback

Hello, Hekerui. You have new messages at Sitush's talk page.
Message added 17:17, 15 September 2013 (UTC). You can remove this notice at any time by removing the {{Talkback}} or {{Tb}} template.[reply]

Sitush (talk) 17:17, 15 September 2013 (UTC)[reply]

Hello, my regards and respect, I am writing to you because I am not fluent in English and I do not have the computer skills to publish articles on wikipedia, I think you could finish this publication based on the technical requirements that I cannot provide, greetings Titanwiki (talk) 17:51, 11 April 2020 (UTC)[reply]

Vaccine: Hebertrans Company & Lead Researcher: Center of Genetic Engineering and Biotechnology Cuba, BioCubaFarma Vaccine Type: ? Status: In production

Vaccine: Heberon Alfa R, Interferón Alfa 2b Company & Lead Researcher: Center of Genetic Engineering and Biotechnology Cuba, BioCubaFarma Vaccine Type: ? Status: In production

Vaccine: EXD-12 Company & Lead Researcher: Excell Biotech LLC Vaccine Type: ? Status: ?

Vaccine: NanoVax Company & Lead Researcher: BlueWillow Biologics Vaccine Type: ? Status: ?

Vaccine: SQX770 Company & Lead Researcher: Squarex Vaccine Type: ? Status: ?

Vaccine: CRISPR Cas9 Company & Lead Researcher: Excision BioTherapeutics Vaccine Type: ? Status: ?

Vaccine: discovery Company & Lead Researcher: Candel Therapeutics, PeriphaGen Vaccine Type: Has acquired all the assets based on the herpes simplex virus (HSV) from PeriphaGen, Inc. The acquired development platform allows precise modifications in the spine of the virus. Status: ?

Vaccine: discovery Company & Lead Researcher: Synergy Pharmaceuticals Vaccine Type: This research shows considerable scope, particularly in the natural approach. Employing specific T Cells generated through a particular Amino Acid formula. The treatment consisted of five immunotherapeutic core compounds (5CC) comprising of Rhodiola, Tribulus, Astragalus, Lysine and a proprietary Amino Acid Formula. Status: ?

Vaccine: discovery Company & Lead Researcher: University of Arizona in Phoenix EEUU Vaccine Type: Discover a function in a cytokine (essential proteins for the immune system) proinflammatory IL-36g, which could play an important role in improving the current and future approach to the herpes virus. Status: ?

Vaccine: discovery Company & Lead Researcher: University of Manchester, University of Geneva, and EPLF in Lausanne Switzerland Vaccine Type: New modified molecules using natural glucose derivatives known as cyclodextrins. The antiviral mechanism is virucidal. Unique new antiviral treatment made using sugar. Status: ?

Vaccine: discovery Company & Lead Researcher: Yale University Vaccine Type: Principal investigator Akiko Iwasaki, Ph.D., and colleagues found that the HSV-2 antibody that the body produces in response to vaccination was not present in the vaginal cavity, where it is most necessary to protect against infection. They also learned that when specialized immune cells, called memory B cells, are physically drawn to the genital area, they produce and insert the antibody in the inner vaginal tissue. HSV2 vaccines may benefit from a prime and pull approach. Status: ?

Vaccine: discovery Company & Lead Researcher: Cornell University Vaccine Type: New research from Dr. Luis M. Schang and his group at the Baker Institute for Animal Health has identified a new mechanism that plays a role in controlling how the herpes virus alternates between dormant and active stages of infection. Discovery reveals mechanism that turns herpes virus on and off. Demonstrating that chromatin dynamics regulates whether the complete genome of the herpes virus is activated, which must occur before individual genes can be expressed. Status: ? Titanwiki (talk) 17:51, 11 April 2020 (UTC)[reply]

DYK nomination of Balderschwang Yew

Did You Know nominations page has been reviewed, and some issues with it may need to be clarified. Please review the comment(s) underneath your nomination's entry and respond there as soon as possible. Thank you for contributing to Did You Know! NinaGreen (talk) 23:55, 10 October 2013 (UTC)[reply
]

Talkback

Hello, Hekerui. You have new messages at Wer900's talk page.
You can remove this notice at any time by removing the {{Talkback}} or {{Tb}} template.

DYK for Balderschwang Yew